These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

130 related items for PubMed ID: 1478337

  • 1. Introduction to the issues: recently developed methods for characterizing cell lines.
    Kozak RW.
    Dev Biol Stand; 1992; 76():21-4. PubMed ID: 1478337
    [Abstract] [Full Text] [Related]

  • 2. Introduction to the issues: appropriate methods of process validation.
    Scribner CL.
    Dev Biol Stand; 1992; 76():213-4. PubMed ID: 1478338
    [No Abstract] [Full Text] [Related]

  • 3. Cell banking.
    Wiebe ME, May LH.
    Bioprocess Technol; 1990; 10():147-60. PubMed ID: 1367056
    [Abstract] [Full Text] [Related]

  • 4. Transmissible spongiform encephalopathies (TSE): minimizing the risk of transmission by biological/biopharmaceutical products: an industry perspective.
    Kozak RW, Golker CF, Stadler P.
    Dev Biol Stand; 1996; 88():257-64. PubMed ID: 9119148
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Detection of adventitious viruses in biologicals--a rare occurrence.
    Nims RW.
    Dev Biol (Basel); 2006; 123():153-64; discussion 183-97. PubMed ID: 16566443
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. An overview of quantitative PCR assays for biologicals: quality and safety evaluation.
    Xu Y, Brorson K.
    Dev Biol (Basel); 2003; 113():89-98. PubMed ID: 14620857
    [Abstract] [Full Text] [Related]

  • 13. Issues of biological assays for viral vaccines.
    Lee CK.
    Dev Biol Stand; 1996; 88():41-7. PubMed ID: 9119161
    [Abstract] [Full Text] [Related]

  • 14. Introduction to the issues: new potential contaminants and other exogenous agents.
    Albrecht P.
    Dev Biol Stand; 1992; 76():255-8. PubMed ID: 1478344
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Control of recombinant DNA produced pharmaceuticals by a combination of process validation and final product specifications.
    Jones AJ, O'Connor JV.
    Dev Biol Stand; 1985; 59():175-80. PubMed ID: 4007276
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.